Literature DB >> 19245171

Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix.

Raimy Mindiola1, Diana Caulejas, José Núñez-Troconis, Mary Araujo, Mariela Delgado, Jesús Mosquera.   

Abstract

Previous studies have shown the involvement of the immune response in the progression of human uterine cervix cancer. The aim of this study was to determine the expression of Interleukin-2 (IL-2), IL-2 receptor (IL-2R) and Interleukin 10 (IL-10) in different grades of cervical intraepithelial neoplasias of the exocervix (CIN 1, 2 and 3), and its relationship with the serum cytokine profiles and human papilomavirus (HPV) infection status. Indirect immunofluorescence was used to study the expression of IL-2, IL-2R and IL-10 in human cervical samples from 50 patients and 9 normal controls. Serum IL-2, IL-2R and IL-10 were measured by ELISA and HPV DNA and HPV types were identified by PCR. Increased number of IL-2, IL-2R and IL-10 positive cells were observed in the cervix from patients with CIN, associated with the grades of dysplasia. A significant correlation was observed between IL-2 and IL-2R (p>0.0001), IL-2 and IL-10 (p>0.0001), as well as IL-10 and IL-2R (p>0.0001). Twenty percent of patients were HPV positive and 84% of those patients were tissue cytokine positive. These results suggest that IL-2, IL-2R and IL-10 tissue expression may play a role in the development of cervical intraepithelial dysplasias.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19245171

Source DB:  PubMed          Journal:  Invest Clin        ISSN: 0535-5133            Impact factor:   0.683


  11 in total

1.  In vitro evidence of the presence of mesenchymal stromal cells in cervical cancer and their role in protecting cancer cells from cytotoxic T cell activity.

Authors:  Juan J Montesinos; María de L Mora-García; Héctor Mayani; Eugenia Flores-Figueroa; Rosario García-Rocha; Guadalupe R Fajardo-Orduña; Marta E Castro-Manrreza; Benny Weiss-Steider; Alberto Monroy-García
Journal:  Stem Cells Dev       Date:  2013-06-14       Impact factor: 3.272

2.  Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.

Authors:  Qinghua Feng; Huafeng Wei; Janice Morihara; Joshua Stern; Mujun Yu; Nancy Kiviat; Ingegerd Hellstrom; Karl Erik Hellstrom
Journal:  Gynecol Oncol       Date:  2012-07-22       Impact factor: 5.482

3.  Serum cytokine analysis in a positive chemoprevention trial: selenium, interleukin-2, and an association with squamous preneoplastic disease.

Authors:  Mark J Roth; Hormuzd A Katki; Wen-Qiang Wei; You-Lin Qiao; Rachel Bagni; Guo-Qing Wang; Denise Whitby; Zhi-Wei Dong; Mitchell H Gail; Paul J Limburg; Carol A Giffen; Philip R Taylor; Sanford M Dawsey
Journal:  Cancer Prev Res (Phila)       Date:  2010-06-29

4.  Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.

Authors:  Stina Syrjänen; Paulo Naud; Luis Sarian; Sophie Derchain; Cecilia Roteli-Martins; Adhemar Longatto-Filho; Silvio Tatti; Margherita Branca; Mojca Erzen; L S Hammes; S Costa; Kari Syrjänen
Journal:  Virchows Arch       Date:  2009-11-12       Impact factor: 4.064

5.  Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth.

Authors:  Aline Bolpetti; João S Silva; Luisa L Villa; Ana Paula Lepique
Journal:  BMC Immunol       Date:  2010-06-07       Impact factor: 3.615

6.  Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions.

Authors:  Thiago Theodoro Martins Prata; Camila Mareti Bonin; Alda Maria Teixeira Ferreira; Cacilda Tezelli Junqueira Padovani; Carlos Eurico dos Santos Fernandes; Ana Paula Machado; Inês Aparecida Tozetti
Journal:  Immunology       Date:  2015-07-01       Impact factor: 7.397

Review 7.  The paradox of IL-10-mediated modulation in cervical cancer.

Authors:  Yan Wang; Xiao-Hong Liu; Yue-Hong Li; Ou Li
Journal:  Biomed Rep       Date:  2013-02-26

8.  IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes.

Authors:  Adriana C Vidal; David Skaar; Rachel Maguire; Seyram Dodor; Laura W Musselwhite; John A Bartlett; Olola Oneko; Joseph Obure; Pendo Mlay; Susan K Murphy; Cathrine Hoyo
Journal:  Infect Agent Cancer       Date:  2015-03-20       Impact factor: 2.965

9.  Differential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas.

Authors:  Chun-Yi Chuang; Wen-Wei Sung; Lee Wang; Wea-Long Lin; Kun-Tu Yeh; Mao-Chang Su; Chun-Han Hsin; Shiann-Yann Lee; Buor-Chang Wu; Ya-Wen Cheng; Huei Lee
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  Cervical cancer cell supernatants induce a phenotypic switch from U937-derived macrophage-activated M1 state into M2-like suppressor phenotype with change in Toll-like receptor profile.

Authors:  Karina Sánchez-Reyes; Alejandro Bravo-Cuellar; Georgina Hernández-Flores; José Manuel Lerma-Díaz; Luis Felipe Jave-Suárez; Paulina Gómez-Lomelí; Ruth de Celis; Adriana Aguilar-Lemarroy; Jorge Ramiro Domínguez-Rodríguez; Pablo Cesar Ortiz-Lazareno
Journal:  Biomed Res Int       Date:  2014-09-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.